Maple Leaf Foods Inc. will consolidate its U.S. plant protein production into a single Plant Protein Centre of Excellence at its Indianapolis, Indiana facility, winding down operations at its plants in Seattle, Washington and Turners Falls, Massachusetts. The transition is expected to occur in phases over approximately 12 to 18 months, with targeted completion in Q4 2027. The decision is part of the company's Fuel for Growth initiative and follows a review of its plant protein manufacturing footprint; consolidating production in Indianapolis is expected to create a more efficient manufacturing network, improve capacity utilization, reduce operational complexity and establish a focused Centre of Excellence. President and Chief Executive Officer Curtis Frank said declining volumes have left the manufacturing network substantially underutilized, and that maintaining three facilities at these utilization levels creates structural costs that are not sustainable over the long term. The expected benefits, costs and capital requirements of the consolidation are included in Maple Leaf Foods' previously disclosed 2030 financial outlook, and the company said it expects to invest in the Indianapolis facility and add team members as production is consolidated.
Consolidating U.S. plant protein production into Indianapolis is expected to create a more efficient network, improve capacity utilization and reduce structural costs.
